A Side Door Into Care Cascade for HIV-Infected Patients?

被引:0
|
作者
Hallett, Timothy B. [1 ]
Eaton, Jeffrey W. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England
基金
比尔及梅琳达.盖茨基金会;
关键词
HIV care cascade; ART programs; surveillance; side door; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; COLLABORATIVE ANALYSIS; SOUTH-AFRICA; SCALE-UP; SEROCONVERSION; INITIATION; RETENTION; ADULTS; TIME;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV Prevention Trials Network studies are testing a number of new technologies for preventing HIV infections and reducing AIDS morbidity and mortality, but strengthening existing antiretroviral therapy (ART) programs may be among the most promising ways to generate greater health benefits using available resources. A cascade to care for HIV-positive patients has been described-HIV testing, retention in pre-ART care, treatment initiation, and sustained suppression on ART-and it has been noted that many patients are lost at each stage. We constructed a detailed representation by combining data from different sources about each stage. We found that, although currently available data were not sufficient to specify several key aspects, the traditional model of the cascade could not fully reconcile trends in HIV testing, linkage to care, retention in pre-ART care, and retention on ART with the large numbers of persons on ART and the large percentage of patients initiating treatment at late stages of infection. We hypothesize that supplementing the traditional linear cascade model with patient health-seeking behaviors that allow patients who are not in pre-ART care to be initiated on ART, is essential to fully characterizing the current functioning of ART programs. We have termed this additional channel to ART as the "side door." Understanding the relative roles of the different channels to care will be important to intervening effectively to improve the cascade to care, and we propose several new types of data that should be collected. With these insights, it may be possible to considerably strengthen the impact of ART programs.
引用
收藏
页码:S228 / S232
页数:5
相关论文
共 50 条
  • [41] Psychopharmacology in HIV-infected patients
    Repetto, Martin J.
    Petitto, John M.
    PSYCHOSOMATIC MEDICINE, 2008, 70 (05): : 585 - 592
  • [42] Osteonecrosis in HIV-infected patients
    Bottaro, EG
    Figueroa, RH
    Scapellato, PG
    Vidal, GI
    Brieschke, MTR
    Da Representaçao, S
    Seoane, MB
    Laurido, MF
    Caiafa, D
    Lopardo, G
    Herrera, F
    Cassetti, I
    MEDICINA-BUENOS AIRES, 2004, 64 (04) : 325 - 331
  • [43] Onychomycosis in HIV-infected patients
    Ravnborg, L
    Baastrup, N
    Svejgaard, E
    ACTA DERMATO-VENEREOLOGICA, 1998, 78 (02) : 151 - 152
  • [44] Thrombocytopenia in HIV-Infected Patients
    Francielle Garcia Nascimento
    Paula Yurie Tanaka
    Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 109 - 111
  • [45] Hemoptysis in HIV-infected patients
    Nelson, JE
    Forman, M
    CHEST, 1996, 110 (03) : 737 - 743
  • [46] Radiotherapy for HIV-infected patients
    Quero, L.
    Gobert, A.
    Spano, J. -P.
    CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 496 - 501
  • [47] Osteoporosis in HIV-infected patients
    Groger R.
    Quirk E.
    Powderly W.G.
    Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (2): : 167 - 173
  • [48] Thrombocytopenia in HIV-Infected Patients
    Nascimento, Francielle Garcia
    Tanaka, Paula Yurie
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (02) : 109 - 111
  • [49] NEUROSYPHILIS IN HIV-INFECTED PATIENTS
    BERGER, JR
    AMERICAN JOURNAL OF MEDICINE, 1993, 95 (06): : 664 - 664
  • [50] NEUROSYPHILIS IN HIV-INFECTED PATIENTS
    BORDON, J
    MARTINEZVAZQUEZ, C
    ALVAREZ, M
    MIRALLES, C
    OCAMPO, A
    DELAFUENTEAGUADO, J
    ARGUELLES, BSP
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (10) : 864 - 869